Last reviewed · How we verify
Vitamin C,thiamine,hydrocortisone — Competitive Intelligence Brief
phase 3
Vitamin: Vitamin B complex, Thiamine: Vitamin B1, Hydrocortisone: Corticosteroid
General Health, Cardiovascular, Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
Vitamin C,thiamine,hydrocortisone (Vitamin C,thiamine,hydrocortisone) — Northern Jiangsu People's Hospital. Vitamin C acts as an antioxidant, thiamine serves as a coenzyme in carbohydrate metabolism, and hydrocortisone is a corticosteroid with anti-inflammatory properties.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vitamin C,thiamine,hydrocortisone TARGET | Vitamin C,thiamine,hydrocortisone | Northern Jiangsu People's Hospital | phase 3 | Vitamin: Vitamin B complex, Thiamine: Vitamin B1, Hydrocortisone: Corticosteroid |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vitamin: Vitamin B complex, Thiamine: Vitamin B1, Hydrocortisone: Corticosteroid class)
- Northern Jiangsu People's Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vitamin C,thiamine,hydrocortisone CI watch — RSS
- Vitamin C,thiamine,hydrocortisone CI watch — Atom
- Vitamin C,thiamine,hydrocortisone CI watch — JSON
- Vitamin C,thiamine,hydrocortisone alone — RSS
- Whole Vitamin: Vitamin B complex, Thiamine: Vitamin B1, Hydrocortisone: Corticosteroid class — RSS
Cite this brief
Drug Landscape (2026). Vitamin C,thiamine,hydrocortisone — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-c-thiamine-hydrocortisone. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab